MAXCYTE INC (MXCT) Earnings History & Surprises

NASDAQ:MXCTUS57777K1060

Current stock price

0.7496 USD
+0.01 (+0.74%)
At close:
0.75 USD
+0 (+0.05%)
After Hours:

MXCT Earnings overview

Past quarterly earnings results for MAXCYTE INC (MXCT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.06
Revenue Estimate
9.085M

Last Reported

Most Recent
Release Date
Mar 24, 2026
Period
Q4 / 2025
EPS Reported
-$0.06
EPS Surprise
26.47%
Revenue Surprise
-23.91%

Beat Rate

Last 8 Quarters
75%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2025 -0.06 -0.08 26.47% 40.00% 7.3M 9.594M -23.91% -16.02%
Q3 2025 -0.09 -0.11 19.79% 18.18% 6.829M 8.537M -20.01% -16.35%
Q2 2025 -0.12 -0.11 -13.86% -33.33% 8.507M 9.719M -12.47% -18.43%
Q1 2025 -0.10 -0.11 6.63% -11.11% 10.39M 9.869M 5.28% -8.39%
Q4 2024 -0.10 -0.12 19.64% -100.00% 8.693M 8.086M 7.51% -44.51%
Q3 2024 -0.11 -0.13 12.56% - 8.164M 7.522M 8.53% 1.99%
Q2 2024 -0.09 -0.13 30.34% 10.00% 10.429M 8.079M 29.09% 15.33%
Q1 2024 -0.09 -0.13 32.13% 18.18% 11.342M 7.611M 49.02% 32.25%
Q4 2023 -0.05 -0.07 31.92% - 15.666M 13.356M 17.30% 26.14%
Q3 2023 -0.11 -0.10 -5.73% -83.33% 8.005M 9.247M -13.44% -24.77%
Q2 2023 -0.10 -0.10 -2.12% -25.00% 9.043M 11.003M -17.82% -5.90%
Q1 2023 -0.11 -0.11 3.71% -175.00% 8.576M 8.495M 0.96% -26.00%
Q4 2022 -0.05 -0.07 29.97% - 12.42M 13.154M -5.58% 22.36%
Q3 2022 -0.06 -0.08 28.26% -100.00% 10.64M 10.639M 0.01% 4.93%
Q2 2022 -0.08 -0.08 1.96% -60.00% 9.61M 9.407M 2.16% 35.16%
Q1 2022 -0.04 -0.07 45.53% - 11.59M 8.629M 34.31% -
Q4 2021 -0.05 -0.06 9.22% 28.57% 10.15M 9.645M 5.24% -33.56%
Q3 2021 -0.03 -0.05 38.73% - 10.14M 7.521M 34.82% -
Q2 2021 -0.05 -0.07 24.59% - 7.11M 5.847M 21.60% -34.73%
Q4 2020 -0.07 -0.10 30.69% - 15.277M - -
Q2 2020 - - 10.892M - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

MXCT EPS Q2Q GrowthMXCT EPS Q2Q GrowthEPS Q2Q Growth Q4/21 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 Q1/27 Q3/27 0 -50 -100 -150

Revenue Historical Q2Q growth and Acceleration

MXCT Revenue Q2Q GrowthMXCT Revenue Q2Q GrowthRevenue Q2Q Growth Q2/21 Q2/22 Q4/22 Q2/23 Q4/23 Q2/24 Q4/24 Q2/25 Q4/25 Q2/26 Q4/26 Q2/27 Q4/27 0 20 -20 40 -40

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
3
Average EPS beat (4)
9.76%
Max EPS beat (4)
26.47%
Min EPS beat (4)
-13.86%

Revenue beat statistics

Revenue beat (4)
1
Average Revenue beat (4)
-12.78%
Max Revenue beat (4)
5.28%
Min Revenue beat (4)
-23.91%

Analysis

In the last 4 quarters, MXCT has beaten EPS estimates in 3 out of 4 releases
MXCT has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, MXCT has beaten the EPS estimates by 9.8% on average.
In the last 4 quarters, MXCT reported -12.8% below the revenue estimates on average.

MAXCYTE INC / MXCT Earnings FAQ

What is the most recent earnings date for MXCT stock?

MAXCYTE INC (MXCT) last reported earnings on 3/24/2026.

Can you provide information on whether MAXCYTE INC beat earnings estimates in the last quarter?

MAXCYTE INC (MXCT) beat EPS estimates and missed revenue estimates in the most recent quarter.

Can you provide information on how often MAXCYTE INC beats earnings estimates?

In the last 4 quarters, MAXCYTE INC (MXCT) has beaten EPS estimates in 3 out of 4 releases.